Trending Online CME/CNE

Current Trends and Future Directions in Targeted Therapies for Advanced Renal Cell Carcinoma

Watch this CME-approved webinar with Brian I. Rini, MD, FACP from Cleveland Clinic Lerner College of Medicine as he discusses emerging data on targeted therapies for the treatment of patients with advanced RCC.

Improving Treatment Outcomes of Patients With Waldenstrom Macroglobulinemia

1.0 CME/CNE | ILNA Points

How can you improve the treatment outcomes for patients with this rare malignancy? This online activity, led by Morie A. Gertz, MD, MACP and Toni Dubeau, RN, NP, will discuss risk stratification, novel therapeutic approaches, and adverse event management. Start now!

Optimizing the Management of Advanced Cervical Cancer With Checkpoint Inhibitor Therapy

1.0 CME/CNE | ILNA Points

This case-based online activity features a discussion between leading clinical investigators, Ramez Eskander, MD and Bradley Monk, MD, FACS, FACOG, as they explore the management of advanced cervical cancer with checkpoint inhibitor therapy.

Challenges and Opportunities in Hodgkin Lymphoma

NEW ACTIVITY | 1.0 CME/CNE

In this online activity, Craig H. Moskowitz, MD and Kami Maddocks, MD discuss factors that increase risk for cHL treatment failure, emerging data on the treatment of newly diagnosed and relapsed/refractory cHL, and assess strategies to manage toxicities associated with therapy.

Implementing New Data and Evolving Standards in Metastatic Triple-Negative Breast Cancer

NEW ACTIVITY | 1.0 CME/CNE

Patients with TNBC have a poorer prognosis than those who present with HR-positive or HER2-positive disease. This CME/CE-approved discussion on metastatic TNBC with Sara Tolaney, MD, MPH and Sara Hurvitz, MD will evaluate personalized care plans, genetic risk evaluation, and novel therapies.

Challenges and Opportunities in Metastatic Gastric Cancer

NEW ACTIVITY | 1.0 CME/CNE

This case-based discussion on metastatic gastric cancer features Jaffer A. Ajani, MD and Allyson J. Ocean, MD as they examine individualized treatment selection, novel therapies, and adverse event management. Register to get started today!

Optimizing Treatment Experiences in Castration-Resistant Prostate Cancer

1.2 CNE| ILNA Points

This online CE-approved activity features a case-based discussion between Kathleen D. Burns, MSN, ANP, OCN® and Brenda Martone, MSN, ANP-BC, AOCNP® on combination and sequential treatment strategies, novel therapies, and adverse event management in CRPC.

Understanding and Optimizing CAR T-Cell Therapy for Patients With B-Cell Malignancies

NEW ACTIVITY | 1.0 CNE

This online strategy session features a discussion between Stephanie Jackson, MSN, RN, AOCNS, BMTCN and Leslie Smith, RN, APRN-CNS, AOCNS on CAR T-cell therapy in patients with B-cell malignancies such as T-cell workflow, efficacy and safety data, as well as adverse event management.

Current Challenges and New Opportunities in Follicular Lymphoma

NEW ACTIVITY | 1.25 CME | 1.2 CNE

Watch this case-based CME/CE-certified recording with Christopher R. Flowers, MD, MS as he discusses emerging data in treatment selection and supportive care for patients with previously untreated and relapsed/refractory FL.

Current Trends in the Management of Castration-Resistant Prostate Cancer

NEW ACTIVITY | 1.0 CME/CNE

In this case-based activity, Alicia K. Morgans, MD, MPH and Tanya Dorff, MD discuss predictive and prognostic markers, recent findings, novel treatments, and supportive care plans for patients with castration-resistant prostate cancer.

Nursing Strategies to Optimize Treatment Experiences in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

NEW ACTIVITY | 1.0 CNE | ILNA Points

In this CE-certified online activity, Constance Visovsky, PhD, RN, ACNP, FAAN discusses treatment planning, CDK4/6 inhibitor safety profiles, and supportive care strategies for patients with metastatic breast cancer.

Best Practices in Nursing Management of Chemotherapy-Induced Peripheral Neuropathy

1.0 CNE | ILNA Points

CIPN is a complication of cancer treatment that may lead to permanent nerve damage in severe cases. This online activity reviews causative agents, signs and symptoms, and supportive care interventions.

Prevention of Medical Errors in Nursing Practice

1.0 CNE | ILNA Points

Medical errors are among the most common health-threatening mistakes that affect patient care. This online activity reviews the categories of medication errors, at-risk patient populations, and best practices in error analysis and reporting.

Nursing Management of Tumor Lysis Syndrome

1.0 CNE | ILNA Points

TLS is an oncological emergency which can result in acute renal failure, cardiac arrhythmias, seizures, and even death. This online activity reviews signs and symptoms, risk factors, and supportive care interventions.

Nursing Management of Venous Thromboembolism in Hospitalized Patients With Cancer

1.0 CNE | ILNA Points

VTE is a life-threatening complication in hospitalized patients with cancer, and is associated with a 2- to 6-fold increase in likelihood of death. This online activity reviews signs and symptoms, risk assessment, and supportive care interventions.

Nursing Management of Venous Thromboembolism in Ambulatory Patients With Cancer

1.0 CNE | ILNA Points

VTE is a common and potentially life-threatening complication in patients with cancer. This online activity reviews venous thromboembolism pathophysiology, risk assessment, and supportive care interventions for ambulatory cancer patients.

Management of Cancer Pain: Current Guidelines

1.0 CNE | ILNA Points

Pain is among the most debilitating symptoms cancer patients experience. This online activity reviews the pathophysiology of cancer pain and scientific principles of pain management, assessment, and emerging concepts in pharmacological management.

CME/CNE Live Meetings

New Thinking, New Strategies in the Treatment of Advanced NSCLC Without Driver Mutations

1.0 CME | Visiting Faculty Meeting Series

Are you developing personalized care plans for your patients with advanced NSCLC? This activity will bring a leading clinical expert to your institution to discuss the use of molecular biomarkers to refine selection of novel therapies. Enroll your institution today!

New Clinical Perspectives in the Management of Myelofibrosis

1.0 CME | Visiting Faculty Meeting Series

This live meeting series will bring a leading clinical investigator to your institution to discuss predictive and prognostic markers, personalized care plans, emerging data, and research advances in the management of myelofibrosis. Request a meeting today!

Current Challenges and New Opportunities in Hematopoietic Stem Cell Transplant

1.0 CME/CNE | Visiting Faculty Meeting Series

This case-based activity will bring a clinical expert to your cancer center to evaluate emerging data that can optimize HSCT outcomes and strategies to manage transplant-related complications. Schedule a meeting at your institution today!

Evolving Treatment Paradigms in Multiple Myeloma and Implications for Shared Decision Making

1.0 CME/CNE/CPE | Visiting Faculty Meeting Series

This activity will bring a leading clinical investigator to your cancer center to discuss personalized care plans, novel therapies, and supportive care strategies for patients with MM. Schedule a meeting at your institution today!

Trending Online CME/CNE

Current Trends and Future Directions in Targeted Therapies for Advanced Renal Cell Carcinoma

Improving Treatment Outcomes of Patients With Waldenstrom Macroglobulinemia

Optimizing the Management of Advanced Cervical Cancer With Checkpoint Inhibitor Therapy

Challenges and Opportunities in Hodgkin Lymphoma

Implementing New Data and Evolving Standards in Metastatic Triple-Negative Breast Cancer

Challenges and Opportunities in Metastatic Gastric Cancer

Optimizing Treatment Experiences in Castration-Resistant Prostate Cancer

Understanding and Optimizing CAR T-Cell Therapy for Patients With B-Cell Malignancies

Current Challenges and New Opportunities in Follicular Lymphoma

Current Trends in the Management of Castration-Resistant Prostate Cancer

Nursing Strategies to Optimize Treatment Experiences in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer

Nursing Management of Oral Mucositis

Nursing Management of Bone Health in Patients With Cancer

Nursing Management of Cancer Treatment-Induced Cardiotoxicity

Best Practices in Nursing Management of Chemotherapy-Induced Peripheral Neuropathy

Prevention of Medical Errors in Nursing Practice

Nursing Management of Tumor Lysis Syndrome

Nursing Management of Venous Thromboembolism in Hospitalized Patients With Cancer

Nursing Management of Venous Thromboembolism in Ambulatory Patients With Cancer

Management of Cancer Pain: Current Guidelines

CME/CNE Live Meetings

New Thinking, New Strategies in the Treatment of Advanced NSCLC Without Driver Mutations

New Clinical Perspectives in the Management of Myelofibrosis

Current Challenges and New Opportunities in Hematopoietic Stem Cell Transplant

Evolving Treatment Paradigms in Multiple Myeloma and Implications for Shared Decision Making

Company

Resources

Follow Us